Work

Current development of mTOR inhibitors as anticancer agents

Year: 2006

Type: review

Source: Nature Reviews Drug Discovery

DOI: 10.1038/nrd2062

Authors: Sandrine Faivre, Guido Kroemer, Eric Raymond

Institutions: Hôpital Beaujon, Centre National de la Recherche Scientifique, Institut Gustave Roussy

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1995197723

FWCI: 5.194

Cites: 178

Cited by: 1,017

Related to: 10